 |
Education: New York University
School of Medicine, New York, NY – 1980
Since arriving in 1991, Dr. Elias' focus has been on experimental therapeutics for breast cancer, describing molecular changes associated with anti-estrogen and/or chemotherapy drug resistance and tissue banking for breast cancer. Another interest is experimental therapy for sarcomas. |
Research
Dr. Elias is focused on clinical breast cancer research and is the director of the clinical breast oncology program. This comprehensive program includes a weekly multi-disciplinary clinic and tumor board, a hereditary clinic, benign breast complaint clinic, a screening and breast imaging program, in addition to daily breast specialty oncology clinics. The sarcoma program includes consult/new patient clinics as well as followups. Dr. Elias is the principal investigator on numerous national and local therapeutic trials and is institution PI for the SWOG grant. He is a member of the SWOG breast committee. He is also the Associate Director of the Cancer Center for clinical sciences and oversees the Clinical Investigations Core.
Funding
SWOG
Pfizer
Roche
Other Pharma
Publications
PubMed articles